Integer Holdings Corporation (NYSE:ITGR) Shares Sold by Readystate Asset Management LP

Readystate Asset Management LP lessened its holdings in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 97.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,757 shares of the medical equipment provider's stock after selling 92,428 shares during the period. Readystate Asset Management LP's holdings in Integer were worth $325,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of ITGR. AdvisorNet Financial Inc purchased a new stake in shares of Integer in the first quarter valued at $28,000. Opal Wealth Advisors LLC acquired a new stake in Integer in the 1st quarter worth about $28,000. Bessemer Group Inc. boosted its stake in Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares during the last quarter. Sterling Capital Management LLC boosted its stake in Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after buying an additional 279 shares during the last quarter. Finally, Contravisory Investment Management Inc. boosted its stake in Integer by 103.9% in the 1st quarter. Contravisory Investment Management Inc. now owns 1,413 shares of the medical equipment provider's stock worth $167,000 after buying an additional 720 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

Shares of NYSE ITGR traded up $1.07 during trading on Friday, reaching $108.17. The stock had a trading volume of 614,623 shares, compared to its average volume of 474,587. Integer Holdings Corporation has a one year low of $104.93 and a one year high of $146.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.14 and a current ratio of 3.41. The stock has a market cap of $3.77 billion, a PE ratio of 47.65, a P/E/G ratio of 0.92 and a beta of 0.98. The firm's 50 day moving average price is $118.78 and its two-hundred day moving average price is $123.71.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million during the quarter, compared to the consensus estimate of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. Integer's revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.30 earnings per share. On average, research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director directly owned 18,781 shares in the company, valued at $2,260,856.78. This represents a 43.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 in the last three months. 2.16% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

ITGR has been the topic of several research analyst reports. Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Truist Financial dropped their target price on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday. KeyCorp dropped their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Raymond James Financial dropped their target price on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a report on Friday. Finally, Wells Fargo & Company dropped their target price on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a report on Friday. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.